Compare HOMB & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HOMB | GRFS |
|---|---|---|
| Founded | 1998 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.5B |
| IPO Year | 2006 | N/A |
| Metric | HOMB | GRFS |
|---|---|---|
| Price | $28.01 | $8.20 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $32.40 | $10.15 |
| AVG Volume (30 Days) | ★ 1.2M | 735.4K |
| Earning Date | 04-15-2026 | 07-28-2022 |
| Dividend Yield | ★ 2.94% | 1.77% |
| EPS Growth | ★ 19.90 | N/A |
| EPS | ★ 2.41 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.99 | $4.69 |
| Revenue Next Year | $5.14 | $6.49 |
| P/E Ratio | ★ $11.85 | $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.98 | $6.85 |
| 52 Week High | $30.83 | $11.14 |
| Indicator | HOMB | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 58.67 | 50.26 |
| Support Level | $27.68 | $7.52 |
| Resistance Level | $28.74 | $9.78 |
| Average True Range (ATR) | 0.51 | 0.21 |
| MACD | 0.27 | 0.09 |
| Stochastic Oscillator | 72.86 | 77.48 |
Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The company has one reportable segment: The Banking Segment.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.